500 related articles for article (PubMed ID: 18499644)
21. High-yielding synthesis of sphingoid-type bases.
Séguin C; Ferreira F; Botuha C; Chemla F; Pérez-Luna A
J Org Chem; 2009 Sep; 74(18):6986-92. PubMed ID: 19673498
[TBL] [Abstract][Full Text] [Related]
22. Effects of sphingoid bases on the sphingolipidome in early keratinocyte differentiation.
Sigruener A; Tarabin V; Paragh G; Liebisch G; Koehler T; Farwick M; Schmitz G
Exp Dermatol; 2013 Oct; 22(10):677-9. PubMed ID: 24079743
[TBL] [Abstract][Full Text] [Related]
23. Characterization of free endogenous C14 and C16 sphingoid bases from Drosophila melanogaster.
Fyrst H; Herr DR; Harris GL; Saba JD
J Lipid Res; 2004 Jan; 45(1):54-62. PubMed ID: 13130120
[TBL] [Abstract][Full Text] [Related]
24. Selective substrate supply in the regulation of yeast de novo sphingolipid synthesis.
Cowart LA; Hannun YA
J Biol Chem; 2007 Apr; 282(16):12330-40. PubMed ID: 17322298
[TBL] [Abstract][Full Text] [Related]
25. Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells.
Ahn EH; Schroeder JJ
Exp Biol Med (Maywood); 2002 May; 227(5):345-53. PubMed ID: 11976405
[TBL] [Abstract][Full Text] [Related]
26. D-Glucosamine-derived synthons for assembly of L-threo-sphingoid bases. Total synthesis of rhizochalinin C.
Ko J; Molinski TF
J Org Chem; 2013 Jan; 78(2):498-505. PubMed ID: 23227909
[TBL] [Abstract][Full Text] [Related]
27. Persistence and reversibility of the elevation in free sphingoid bases induced by fumonisin inhibition of ceramide synthase.
Enongene EN; Sharma RP; Bhandari N; Miller JD; Meredith FI; Voss KA; Riley RT
Toxicol Sci; 2002 Jun; 67(2):173-81. PubMed ID: 12011476
[TBL] [Abstract][Full Text] [Related]
28. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
[TBL] [Abstract][Full Text] [Related]
29. Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response.
Mandala SM; Thornton R; Tu Z; Kurtz MB; Nickels J; Broach J; Menzeleev R; Spiegel S
Proc Natl Acad Sci U S A; 1998 Jan; 95(1):150-5. PubMed ID: 9419344
[TBL] [Abstract][Full Text] [Related]
30. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.
Fabrias G; Muñoz-Olaya J; Cingolani F; Signorelli P; Casas J; Gagliostro V; Ghidoni R
Prog Lipid Res; 2012 Apr; 51(2):82-94. PubMed ID: 22200621
[TBL] [Abstract][Full Text] [Related]
31. Stereoselective Synthesis of Novel Sphingoid Bases Utilized for Exploring the Secrets of Sphinx.
Saied EM; Arenz C
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360937
[TBL] [Abstract][Full Text] [Related]
32. Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices.
Riley RT; Norred WP; Wang E; Merrill AH
Nat Toxins; 1999; 7(6):407-14. PubMed ID: 11122537
[TBL] [Abstract][Full Text] [Related]
33. Highly efficient preparation of sphingoid bases from glucosylceramides by chemoenzymatic method.
Gowda SG; Usuki S; Hammam MA; Murai Y; Igarashi Y; Monde K
J Lipid Res; 2016 Feb; 57(2):325-31. PubMed ID: 26667669
[TBL] [Abstract][Full Text] [Related]
34. Deoxysphingoid bases as plasma markers in diabetes mellitus.
Bertea M; Rütti MF; Othman A; Marti-Jaun J; Hersberger M; von Eckardstein A; Hornemann T
Lipids Health Dis; 2010 Aug; 9():84. PubMed ID: 20712864
[TBL] [Abstract][Full Text] [Related]
35. Sphingoid bases and their involvement in neurodegenerative diseases.
Goins L; Spassieva S
Adv Biol Regul; 2018 Dec; 70():65-73. PubMed ID: 30377075
[TBL] [Abstract][Full Text] [Related]
36. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
37. Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease.
Merrill AH; Stokes TH; Momin A; Park H; Portz BJ; Kelly S; Wang E; Sullards MC; Wang MD
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S97-102. PubMed ID: 19029065
[TBL] [Abstract][Full Text] [Related]
38. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
Yoo HS; Norred WP; Showker J; Riley RT
Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
[TBL] [Abstract][Full Text] [Related]
39. Expression of the ORMDLS, modulators of serine palmitoyltransferase, is regulated by sphingolipids in mammalian cells.
Gupta SD; Gable K; Alexaki A; Chandris P; Proia RL; Dunn TM; Harmon JM
J Biol Chem; 2015 Jan; 290(1):90-8. PubMed ID: 25395622
[TBL] [Abstract][Full Text] [Related]
40. Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis.
Desai K; Sullards MC; Allegood J; Wang E; Schmelz EM; Hartl M; Humpf HU; Liotta DC; Peng Q; Merrill AH
Biochim Biophys Acta; 2002 Dec; 1585(2-3):188-92. PubMed ID: 12531553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
